Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies - Contingent Consideration (Details)

v3.20.2
Commitments and Contingencies - Contingent Consideration (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Dec. 31, 2019
 [1]
Apr. 07, 2019
Feb. 25, 2019
Commitments And Contingencies        
Contingent consideration under royalty purchase agreements $ 75 $ 75    
Change in fair value 0      
Aronora        
Commitments And Contingencies        
Milestone liability 0      
Royalty Purchase Agreement | Bioasis Technologies Inc        
Commitments And Contingencies        
Contingent consideration under royalty purchase agreements       $ 100
Royalty Purchase Agreement | Aronora        
Commitments And Contingencies        
Contingent consideration under royalty purchase agreements     $ 3,000  
Change in fair value 0      
Estimated fair value of contingent consideration $ 0      
[1] The consolidated balance sheet as of December 31, 2019 has been derived from the audited consolidated financial statements as of that date included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.